Live Price
Live Volume
Chart Volume 0
Volume 0
5 secCartesian Therapeutics Market Segments
After Hours
+0.00(+0.00%)
| Open | $6.75 |
|---|---|
| Close | $6.75 |
| Low | $6.75 |
| Low Change | 0.00 (0.00%) |
| High | $6.75 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 16.124K |
| Dollar Volume | $108.84K |
Regular Trading Hours
+0.01(+0.15%)
| Open | $6.76 |
|---|---|
| Close | $6.77 |
| Low | $6.63 |
| Low Change | -0.13 (-1.92%) |
| High | $6.97 |
| High Change | +0.21 (+3.11%) |
| Range | $0.34 |
| Volume | 83.297K |
| Dollar Volume | $563.92K |
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
-0.22(-3.25%)
| Open | $6.69 |
|---|---|
| Close | $6.47 |
| Low | $6.47 |
| Low Change | -0.22 (-3.25%) |
| High | $6.69 |
| High Change | +0.00 (+0.00%) |
| Range | $0.22 |
| Volume | 11.092K |
| Dollar Volume | $71.79K |
Regular Trading Hours Yesterday
+0.29(+4.51%)
| Open | $6.43 |
|---|---|
| Close | $6.72 |
| Low | $6.29 |
| Low Change | -0.14 (-2.18%) |
| High | $6.73 |
| High Change | +0.30 (+4.67%) |
| Range | $0.44 |
| Volume | 92.761K |
| Dollar Volume | $623.35K |
Premarket Yesterday
*No Trades in Segment
Cartesian Therapeutics News
Cartesian Therapeutics Top Trades
Cartesian Therapeutics's top trade so far today returned +3.11%, while the top short trade returned -3.16%.
Cartesian Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $6.42 |
|---|---|
| 10 Day Moving Average (SMA10) | $6.38 |
| 20 Day Moving Average (SMA20) | $6.64 |
| 50 Day Moving Average (SMA50) | $7.89 |
| 100 Day Moving Average (SMA100) | $8.33 |
| 200 Day Moving Average (SMA200) | $7.66 |
Cartesian Therapeutics Statistics
| Average Volume (30 Days) | 135.1K |
|---|---|
| P/E Ratio (Current) | -1.39 |
| EPS (Current) | -$5.09 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$78.61M |
| Cash Ratio | 7.18 |
| Current Ratio | 7.48 |
| Quick Ratio | 7.48 |
| Debt to Equity | -0.42 |
| Enterprise Value | $118.85M |
| EV to EBITDA | -1.24 |
| EV to Sales | 80.47 |
| Price to Book | -1.71 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 144.62 |
| Return on Assets | -0.48% |
| Return on Equity | 1.23% |
Cartesian Therapeutics Stock Splits
There have been 2 stock splits for Cartesian Therapeutics (RNAC). The last reverse stock split occured on April 5, 2024 and reduced the outstanding shares at a ratio of 30:1.
| Date | Type | Ratio |
|---|---|---|
| Apr 5, 2024 | Reverse | 30:1 |
| Dec 1, 2023 | Forward | 1:2 |
Cartesian Therapeutics Dividends
There have been no dividends for Cartesian Therapeutics (RNAC).